Testosterone Links Cardiovascular Risk
Previous studies on the link between heart attack and testosterone therapy have come under scrutiny lately by several groups. The most recent being Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA.
He discusses the flawed study that pointed to the risk of heart attacks with testosterone therapy and discusses how in fact testosterone therapy can indeed reduce risk factors for heart disease.
Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA, along with his coauthors, explore and clarify in the February 2015 issue of Mayo Clinic Proceedings, the value of testosterone therapy in men, and in particular the issue of cardiovascular risk.
Testosterone Therapy properly managed can decrease risk factors for heart attacks in men. He discusses the flawed study that was published: